Search Results
Shaji Kumar | ASH 2018 | Some key highlights
Shaji Kumar, ASCO 2018 – Advances in treatment approaches and guidelines for multiple myeloma
Shaji Kumar, MD
Shaji Kumar | ESH MM 2018 | New end-point and new design for clinical trials
Shaji Kumar | ASCO 2018 | The multifaceted nature of the multiple myelomas
What (Else) to Expect: 2018 Highlights of ASH in Asia-Pacific (Register Now!)
Shaji Kumar, MD, shares his thoughts on whether multiple myeloma can be cured one day
Targeting cell survival in myeloma
Shaji Kumar, MD, explains how immunotherapies are being integrated into treatment algorithms for MM
Shaji Kumar, MD, discusses the most exciting treatment options for multiple myeloma today
Shaji Kumar on Later Lines of Treatment for Myeloma
ASH 2020 - Highlights in Myeloma
